Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Michael Benatar(University of Miami), G. Garcia Gutierrez, Yindi Li(University of Iowa), Volkan Granit(Biohaven Pharmaceuticals (United States)), Lyle W. Ostrow(Johns Hopkins University), Lily Wang(National Tsing Hua University), Stephan Züchner(University of Miami), Patrice L. Whitehead, Ted M. Burns(The University of Texas at San Antonio Health Science Center), Constantine Farmakidis, Julie Steele(University of South Florida), Jaya Trivedi(The University of Texas at San Antonio Health Science Center), Sumaira Hussain, Natalia Ravelo, Marielle Wallace, Rosa Rademakers(University of Antwerp), Jacob L. McCauley(University of Cambridge), Mazen M. Dimachkie, Mamatha Pasnoor, James B. Caress(The University of Texas at San Antonio Health Science Center), Melanie Glenn, Omar Jawdat, Wendy Levy, Anne Cooley(University of Iowa), Andrea Malaspina(Queen Mary University of London), Jeffrey Statland(The University of Texas at San Antonio Health Science Center), Erik P. Pioro(Cleveland Clinic), Jéssica Medina, Tina Liu, Carlayne E. Jackson(The University of Texas at San Antonio Health Science Center), Andrea Swenson(The University of Texas at San Antonio Health Science Center), John Ravits(Columbia University Irving Medical Center), Melissa Currence, Jeri Sieren, Hellen Tanui, Ayla McCally, Yolanda Harness, Jessica Hernandez, Maria Elena Paredes, Emilee Gibson, Andrew Heim, Joanne Wuu(The University of Texas at San Antonio Health Science Center), Ashley Manso, Laura Herbelin, Richard J. Barohn(University of Kansas Medical Center), Jonathan Katz(The University of Texas at San Antonio Health Science Center), Sherri Anderson, Duaa Jabari, Michaela Walker, Lanyu Zhang(The University of Texas at San Antonio Health Science Center)
Neurology
May 8, 2020
Cited by 201


Related Papers